Avail Investment Partners’s Pfizer PFE Stock Holding History

Avail Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$379K	Buy	15,747 +7,378	+88%	+$193K	0.29%	91
2026 Q1	$235K	Buy	+8,369	New	+$223K	0.25%	106

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Avail Investment Partners's PFE Position: Q2 2026 in Review

Avail Investment Partners increased its Pfizer (PFE) stake by 88% in Q2 2026, buying an estimated $193K and bringing the position to 15,747 shares worth $379K. The position accounts for 0.29% of the portfolio, ranked #91.

Avail Investment Partners first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,815 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Avail Investment Partners held 15,747 shares of Pfizer worth $379K as of Q2 2026.
Avail Investment Partners bought 7,378 Pfizer shares in Q2 2026, an estimated $193K.
Pfizer made up 0.29% of Avail Investment Partners's portfolio in Q2 2026, its #91 holding.
Avail Investment Partners first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
2,815 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Avail Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.